Keith Kaye, MD
Infectious Disease · Ann Arbor, MINPI 1083777858
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $158,784 of the $187,232 with a category attached, or 84.8%. 12 manufacturers reported payments, led by GSK at 57.6% of the total. Reporting peaked in 2024 at $60,952 and has fallen 94.7% since, to $3,259 in 2025. Among infectious disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $1930.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$108K
- Merck$21K
- Shionogi Inc$17K
- AbbVie$14K
- Genentech, Inc.$11K
- Xellia Pharmaceuticals$6K
- plus $11K from 6 others
Across 14 payments — averaging $45,134 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$632K
What the payments were for
- Consulting fees$158,78485%
- Speaking & faculty fees$12,9257%
- Grants$4570%
- Travel & lodging$13,9507%
- Food & beverage$1,0811%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 37 | $107,805 |
| Merck | 10 | $20,676 |
| Shionogi Inc | 11 | $17,099 |
| AbbVie | 15 | $14,147 |
| Genentech, Inc. | 3 | $10,800 |
| Xellia Pharmaceuticals | 8 | $5,616 |
| Janssen Global Services, LLC | 1 | $4,320 |
| BD | 3 | $4,113 |
| Ferring Pharmaceuticals Inc. | 1 | $2,390 |
| Melinta Therapeutics, LLC | 5 | $159 |
| Paratek Pharmaceuticals, Inc. | 2 | $71 |
| Astellas Pharma US Inc | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$187,232 in reported general payments places this provider in the 95th percentile of 257 infectious disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Ann Arbor
- Owen AlbinAnn Arbor$25K
- David MarkovitzAnn Arbor$24K
- Payal PatelAnn Arbor$23K
- Marisa MiceliAnn Arbor$19K
- Adam LauringAnn Arbor$7K
- Krishna RaoAnn Arbor$3K
- Laraine WasherAnn Arbor$3K
- Suzanne BradleyAnn Arbor$2K
- Peter GulickLansing$850K
- Teena ChopraDetroit$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.